Increased expression of platelet-derived growth factor receptor alpha and beta and vascular endothelial growth factor in the skin of patients with chronic venous insufficiency

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Archives of Dermatological Research

• Publication date

  1998-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s004030050307PMID 9705159
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor/vascular endothelial growth factor.

  1997cited by this paper
• Microvascular Changes in Venous Disease: An Update

  1997cited by this paper
• Changes of cytokeratin expression in the epidermis with chronic venous insufficiency.

  1997cited by this paper
• Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin.

  1997cited by this paper
• Human neutrophils secrete vascular endothelial growth factor

  1997cited by this paper
• Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia

  1997cited by this paper
• Pericyte loss and microaneurysm formation in PDGF-B-deficient mice.

  1997cited by this paper
• Reduced expression of PDGF and PDGF receptors during impaired wound healing.

  1997cited by this paper
• Expression of vascular endothelial growth factor in normal epidermis, epithelial tumors and cultured keratinocytes

  1997cited by this paper
• Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine.

  1997cited by this paper
• Antisense oligonucleotides inhibit vascular endothelial growth factor/vascular permeability factor expression in normal human epidermal keratinocytes.

  1997cited by this paper
• Vascular endothelial growth factor production in normal epidermis and in benign and malignant epithelial skin tumors.

  1996cited by this paper
• Expression of the adhesion molecules ICAM-1, VCAM-1, and E-selectin and their ligands VLA-4 and LFA-1 in chronic venous leg ulcers.

  1996cited by this paper
• Clinical histochemical and immunohistochemical investigation of the capillary basal membrane in chronic venous insufficiency.

  1996cited by this paper
• Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1.

  1996cited by this paper
• Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions.

  1995cited by this paper
• Regulation of Vascular Endothelial Growth Factor Expression in Cultured Keratinocytes.

  1995cited by this paper
• Extravasation of macromolecules and possible trapping of transforming growth factor‐β in venous ulceration

  1995cited by this paper
• Human keratinocytes express the three major splice forms of vascular endothelial growth factor.

  1995cited by this paper
• Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme.

  1995cited by this paper
• Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis

  1994cited by this paper
• PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors

  1994cited by this paper
• Growth factors and wound healing.

  1994cited by this paper
• Human keratinocytes are a major source of cutaneous platelet-derived growth factor.

  1993cited by this paper
• Delivery of growth factor to wounds using a genetically engineered biological bandage.

  1993cited by this paper
• White cells, skin blood flow and venous ulcers.

  1993cited by this paper
• Tissue localization of beta receptors for platelet-derived growth factor and platelet-derived growth factor B chain during wound repair in humans.

  1993cited by this paper
• Chronic wounds: pathophysiologic and experimental considerations.

  1993cited by this paper
• Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes.

  1993cited by this paper
• Immunohistochemical investigation of dermal capillaries in chronic venous insufficiency.

  1991cited by this paper
• Injury induces in vivo expression of platelet-derived growth factor (PDGF) and PDGF receptor mRNAs in skin epithelial cells and PDGF mRNA in connective tissue fibroblasts.

  1991cited by this paper
• Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels

  1991cited by this paper
• Platelet-derived growth factor (PDGF) stimulates PDGF receptor subunit dimerization and intersubunit trans-phosphorylation.

  1991cited by this paper
• Angiogenesis during human extraembryonic development involves the spatiotemporal control of PDGF ligand and receptor gene expression.

  1991cited by this paper
• White cells, skin blood flow and venous ulcers

  1991cited by this paper
• Increased expression of platelet-derived growth factor type B receptors in the skin of patients with systemic sclerosis.

  1990cited by this paper
• Increased dermal expression of platelet-derived growth factor receptors in growth-activated skin wounds and psoriasis.

  1990cited by this paper
• Cytokine modulation of keratinocyte cytokines.

  1990cited by this paper
• Microvascular permeability, venous stasis and oedema.

  1989cited by this paper
• Changes in endothelial cell mass, luminal volume and capillary number in the gravitational syndrome

  1989cited by this paper
• Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.

  1989cited by this paper
• Growth factors. Their biology and promise in dermatologic diseases and tissue repair.

  1989cited by this paper
• Vascular endothelial growth factor is a secreted angiogenic mitogen.

  1989cited by this paper
• Microvascular permeability, venous stasis and oedema.

  1989cited by this paper
• White cell accumulation in dependent legs of patients with venous hypertension: a possible mechanism for trophic changes in the skin: Thomas PRS, Nash GB, Dormandy JA. Br Med J 1988;296:1693-5

  1989cited by this paper
• White cell accumulation in dependent legs of patients with venous hypertension: a possible mechanism for trophic changes in the skin

  1988cited by this paper
• Cloning and expression of a cDNA coding for the human platelet-derived growth factor receptor: evidence for more than one receptor class.

  1988cited by this paper
• Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing.

  1986cited by this paper
• Pericapillary fibrin in the ulcer-bearing skin of the leg: the cause of lipodermatosclerosis and venous ulceration.

  1982cited by this paper
• On the pathogenesis of the venous leg ulcer.

  1968cited by this paper

• Human umbilical cord Wharton's jelly mesenchymal cell medium progress the wound healing via cytokines and growth factors expressions.

  2025cites this paper
• An appraisal of vascular endothelial growth factor (VEGF): the dynamic molecule of wound healing and its current clinical applications

  2022cites this paper
• Venous overload choroidopathy: A hypothetical framework for central serous chorioretinopathy and allied disorders.

  2021cites this paper
• Management of chronic venous disorders of the lower limbs. Guidelines According to Scientific Evidence. Part I.

  2020cites this paper
• Why Venous Leg Ulcers Have Difficulty Healing: Overview on Pathophysiology, Clinical Consequences, and Treatment

  2020cites this paper
• Allele rs2010963 C of the VEGFA gene is associated with the decreased risk of primary varicose veins in ethnic Russians

  2018cites this paper
• Behavior of Smooth Muscle Cells under Hypoxic Conditions: Possible Implications on the Varicose Vein Endothelium

  2018cites this paper
• The Role of Endothelium in Physiological and Pathological States: New Data

  2018influential citation
• Chronic venous disease - Part I: Inflammatory biomarkers in wound healing.

  2016cites this paper
• Chronic and non-healing wounds: The story of vascular endothelial growth factor.

  2015cites this paper
• Biochemical and pharmacological characterization of a toxic fraction and its cytotoxin-like component isolated from Russell's viper (Daboia russelii russelii) venom.

  2015cites this paper
• Omics profiles in chronic venous ulcer wound fluid: innovative applications for translational medicine

  2014cites this paper
• Microvessel density and expression of vascular endothelial growth factor and its receptors in different subtypes of primary cutaneous B-cell lymphoma.

  2013cites this paper
• The Effect of Secretory Factors of Adipose-Derived Stem Cells on Human Keratinocytes

  2012cites this paper
• Management of primary venous disorders in C6 patients.

  2010cites this paper
• Abundance of plasma cells in a case of lipodermatosclerosis.

  2010cites this paper
• Pharmacological treatment in patients with C4, C5 and C6 venous disease

  2010cites this paper
• Natural history and progression of primary chronic venous disorder.

  2010cites this paper
• The role of vascular endothelial growth factor in wound healing.

  2009cites this paper
• Inhibition of angiogenesis in lipodermatosclerosis: implication for venous ulcer formation.

  2009cites this paper
• Prise en charge des affections veineuses chroniques des membres inférieurs: Recommandations basées sur les preuves scientifiques

  2009cites this paper
• PERSPECTIVE ARTICLE: Growth factors and cytokines in wound healing

  2008cites this paper
• Management of chronic venous disorders of the lower limbs: guidelines according to scientific evidence.

  2008cites this paper
• Pathophysiology of Chronic Venous Insufficiency

  2007cites this paper
• Recent insights into the causes of chronic leg ulceration in venous diseases and implications on other types of chronic wounds

  2007cites this paper
• MICROCIRCULATION IN CHRONIC VENOUS INSUFFICIENCY

  2007cites this paper
• Expression of growth factors and growth factor receptor in non-healing and healing ischaemic ulceration.

  2006cites this paper
• Pathophysiology of Leg Ulceration

  2006cites this paper
• Causes of severe chronic venous insufficiency.

  2005cites this paper
• Procollagen type I gene expression and cell proliferation are increased in lipodermatosclerosis

  2005cites this paper
• Keratinocyte and dermal vascular endothelial cell capacities remain unimpaired in the margin of chronic venous ulcer

  2004cites this paper
• Treatment of Experimental Neuroblastoma with Angiogenic Inhibitors

  2003cites this paper
• Deciphering the impaired cytokine cascades in chronic leg ulcers (review).

  2003cites this paper
• Increased but ineffectual angiogenic drive in nonhealing venous leg ulcers.

  2003cites this paper
• Effect of Oxidized Low-Density Lipoprotein on Differential Gene Expression in Primary Human Endothelial Cells

  2003cites this paper
• Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1279 Treatment of Experimental Neuroblastoma with Angiogenic Inhibitors

  2003cites this paper
• Effect of venous ulcer exudates on angiogenesis in vitro

  2002cites this paper
• Platelet-derived growth factor inhibits basic fibroblast growth factor angiogenic properties in vitro and in vivo through its alpha receptor.

  2002cites this paper
• Dermal Changes in the Lower Leg Skin of Patients With Venous Hypertension

  2002cites this paper
• Increased plasma total nitric oxide among patients with severe chronic venous disease.

  2002cites this paper
• Lipodermatosclerosis: review of cases evaluated at Mayo Clinic.

  2002cites this paper
• Expression of cyclooxygenase isoforms in normal human skin and chronic venous ulcers

  2001cites this paper
• Modulation of urokinase-type and tissue-type plasminogen activator occurs at an early stage of progressing stages of chronic venous insufficiency.

  2000cites this paper
• Causes and effects of the chronic inflammation in venous leg ulcers.

  2000cites this paper
• Expression of nitric oxide synthase isoforms and arginase in normal human skin and chronic venous leg ulcers

  2000cites this paper
• Immunohistochemistry and Molecular Biology of Skin with Chronic Venous Insufficiency and Venous Ulceration

  1999cites this paper
• Cytokines in progressing stages of chronic venous insufficiency.

  1999cites this paper
• Expression of the adhesion molecules ICAM-1, VCAM-1, LFA-1 and VLA-4 in the skin is modulated in progressing stages of chronic venous insufficiency.

  1999cites this paper
• Patterns of epidermal growth factor receptor, basic fibroblast growth factor and transforming growth factor-beta3 expression in skin with chronic venous insufficiency.

  1998cites this paper
• Expression and Distribution of Laminin, Fibronectin and Tenascin is Stage Dependently Modulated in the Skin of Chronic Venous Insufficiency

  1998cites this paper
• The Role of Vascular Endothelial Growth Factor in Wound Healing

  year unknowncites this paper